Last Updated: May 14, 2026

Suppliers and packagers for premarin


✉ Email this page to a colleague

« Back to Dashboard


premarin

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Wyeth Pharms PREMARIN estrogens, conjugated CREAM;TOPICAL, VAGINAL 020216 NDA Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. 0046-0872-04 1 TUBE, WITH APPLICATOR in 1 CARTON (0046-0872-04) / 4 g in 1 TUBE, WITH APPLICATOR 1978-11-01
Wyeth Pharms PREMARIN estrogens, conjugated CREAM;TOPICAL, VAGINAL 020216 NDA Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. 0046-0872-21 1 TUBE, WITH APPLICATOR in 1 CARTON (0046-0872-21) / 30 g in 1 TUBE, WITH APPLICATOR 1978-11-01
Wyeth Pharms PREMARIN estrogens, conjugated INJECTABLE;INJECTION 010402 NDA Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. 0046-0749-05 1 VIAL in 1 CARTON (0046-0749-05) / 5 mL in 1 VIAL 1956-12-01
Wyeth Pharms PREMARIN estrogens, conjugated TABLET;ORAL 004782 NDA Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. 0046-1100-52 1 BLISTER PACK in 1 CARTON (0046-1100-52) / 5 TABLET, FILM COATED in 1 BLISTER PACK 2006-01-01
Wyeth Pharms PREMARIN estrogens, conjugated TABLET;ORAL 004782 NDA Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. 0046-1100-81 100 TABLET, FILM COATED in 1 BOTTLE (0046-1100-81) 2006-01-01
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers and packagers for premarin

Last updated: April 26, 2026

Premarin Suppliers: Market Structure, Upstream Inputs, and Contracting Patterns

What counts as a “supplier” for Premarin Premarin (conjugated estrogens) is a branded hormone therapy whose manufacturing chain typically splits into (1) upstream sourcing of the steroid raw material(s) and (2) contract manufacturing and formulation/packaging execution for the marketed drug. In practice, “suppliers” in the Premarin ecosystem usually map to either steroid-production feedstocks or to pharma manufacturing partners under license for finished-dose production.

Who supplies the Premarin branded product

Premarin is marketed in the US by Pfizer (brand owner). Pfizer’s role is brand responsibility and commercialization, and its manufacturing execution is commonly handled via internal manufacturing sites and/or contract manufacturing arrangements, depending on the dosage form and package configuration.

Brand owner

  • Pfizer (US marketing authorization holder for Premarin products)

Key implication for supplier mapping

  • “Premarin supplier” in procurement terms is usually either Pfizer (finished product) or the listed manufacturers on the FDA labels for specific strength/forms.

Which companies appear as manufacturers on Premarin labels

Premarin includes multiple dosage strengths and dosage forms (commonly tablets and sometimes vaginal products in other estrogen product lines). For procurement and regulatory diligence, the controlling “supplier” list is the set of firms named as manufacturers on the FDA label for each listed NDC/strength.

What label manufacturers typically look like in FDA practice

  • Finished dose manufacturing site (the firm named under “Manufactured for/Distributed by” or “Manufactured by” on product labeling)
  • Secondary packaging sites may be listed separately depending on labeling format and NDC configuration

Actionable mapping logic

  • If you need “suppliers” for buying finished Premarin, you track NDC-specific label manufacturers.
  • If you need “suppliers” for sourcing the chemical precursor stream, you track upstream steroid feedstock suppliers used to make conjugated estrogens.

Upstream input suppliers: where the steroid feedstock originates

Conjugated estrogens in Premarin are made from steroid feedstocks derived from natural sources (historically equine origin is the well-known industrial narrative). Upstream “suppliers” here are the firms that provide steroid intermediates or refined raw materials that feed the conjugation/processing line.

Common upstream category

  • Steroid raw material processors supplying intermediates used for conjugated estrogen production

Contracting pattern

  • The upstream steroid supply is usually controlled under long-term sourcing agreements because it impacts consistency of the estrogen composition profile and regulatory release specifications.

Finished-dose manufacturing and contracting structure

Typical roles in the Premarin supply chain

  1. Brand owner/commercialization entity
    • Holds marketing responsibilities and ensures compliance across product lifecycle.
  2. Manufacturing site(s)
    • Produce drug substance (if integrated) or drug product via blending, tableting/coating, and packaging.
  3. Packaging and label execution
    • May be performed by the same manufacturer or by a packaging partner listed on labeling.

How to treat “suppliers” for R&D or investment

  • For procurement: treat FDA label manufacturers for each NDC as the supplier list you can contract with through distributors/wholesalers.
  • For process development: treat the upstream chemical feedstock suppliers and toll manufacturers as the industrial partner universe.

Data-backed supplier identification using FDA product labeling

How Premarin supplier lists are built in regulated procurement

Supplier identification for each Premarin product SKU is done by:

  • Selecting the specific Premarin NDC and strength
  • Reading the FDA-approved label and recording the named manufacturer/distributor entities

Regulatory databases that contain manufacturer names

Use these to extract label-based supplier names consistently:

  • FDA Orange Book: lists approved products and often includes information relevant to manufacturing/distribution status.
  • FDA Labels (Drugs@FDA): contains current label text with manufacturer/distributor statements.

What this means for a supplier list you can act on

A complete, procurement-grade supplier list for Premarin requires NDC-specific extraction from FDA labeling, because each strength or formulation can point to different manufacturing sites.

Supplier categories you can contract against

  • Finished product suppliers (through labeled manufacturer sites and authorized distributors)
  • Toll manufacturing / packaging partners (for specific dosage forms)
  • Upstream steroid raw material processors (for the feedstock chain)

Current hard anchor for branding

  • Pfizer is the controlling branded product owner for Premarin in the US.

Key Takeaways

  • Premarin “suppliers” resolve into two supplier layers: brand owner/finished product and label-identified manufacturing sites by NDC/strength.
  • Pfizer is the US brand owner for Premarin.
  • For an actionable supplier list, procurement-grade supplier names must be extracted from FDA label text for each Premarin NDC/strength, then mapped to upstream steroid feedstock categories if needed.
  • The upstream estrogen raw material chain typically involves steroid processors under regulated sourcing controls due to composition and release-spec consistency.

FAQs

1) Who is the brand owner supplier for Premarin in the US?

Pfizer is the US Premarin brand owner.

2) Are Premarin manufacturers the same across all strengths and dosage forms?

No. Label manufacturers can vary by NDC/strength/form, so supplier mapping should be NDC-specific.

3) Where do you get the authoritative manufacturer names for Premarin?

From the FDA-approved label text via Drugs@FDA and related FDA resources.

4) What type of companies supply the upstream materials for conjugated estrogens?

Typically steroid raw material processors and refined intermediate suppliers that feed conjugated estrogen manufacturing.

5) What is the most reliable method to build a procurement-grade supplier list?

Extract manufacturer/distributor entities from the FDA label for each Premarin NDC, then map those to authorized distribution channels.


References (APA)

[1] FDA. (n.d.). Drugs@FDA: Premarin (conjugated estrogens). U.S. Food and Drug Administration. https://www.accessdata.fda.gov/scripts/cder/daf/
[2] FDA. (n.d.). FDA Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations (Premarin). U.S. Food and Drug Administration. https://www.accessdata.fda.gov/scripts/cder/ob/

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.